Downregulation of hepatic acetylation of drugs in chronic renal failure

Journal of the American Society of Nephrology

Volumn 19, Issue 7, 2008, Pages 1352-1359

  Simard, Emilie ^a,b   Naud, Judith ^a,b   Michaud, Josée ^a,b   Leblond, Francois A ^a   Bonnardeaux, Alain ^a   Guillemette, Chantal ^c   Sim, Edith ^d   Pichette, Vincent ^a,b,e  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; PARATHYROID HORMONE; 4 AMINOBENZOIC ACID; ISOENZYME; MESSENGER RNA; N ACETYLTRANSFERASE 1; N-ACETYLTRANSFERASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACETYLATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; LIVER; LIVER CELL; N ACETYLTRANSFERASE GENE; NONHUMAN; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; ACETYLATION; ANIMAL; BLOOD; BODY WEIGHT; DRUG DETOXIFICATION; ENZYMOLOGY; GENETICS; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UREMIA;

4-AMINOBENZOIC ACID; ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BODY WEIGHT; DOWN-REGULATION; GENE EXPRESSION; HEPATOCYTES; ISOENZYMES; KIDNEY FAILURE, CHRONIC; LIVER; MALE; METABOLIC DETOXICATION, DRUG; PARATHYROID HORMONE; PARATHYROIDECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UREMIA;

EID: 48149090236     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007090974     Document Type: Article

References (51)

1. Matzke GR, Frye RF: Drug administration in patients with renal insufficiency: Minimising renal and extrarenal toxicity. Drug Saf 16: 205-231, 1997
2. Lam YW, Banerji S, Hatfield C, Talbert RL: Principles of drug administration in renal insufficiency. Clin Pharmacokinet 32: 30-57, 1997
3. Touchette MA, Slaughter RL: The effect of renal failure on hepatic drug clearance. DICP 25: 1214-1224, 1991
4. Talbert RL: Drug dosing in renal insufficiency. J Clin Pharmacol 34: 99-110, 1994
5. Cantu TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser DM: Drug prescribing for patients with changing renal function. Am J Hosp Pharm 49: 2944-2948, 1992
6. Pichette V, Leblond F: Metabolism of drugs in chronic renal failure. Recent Res Dev Drug Metab Dispos 1: 43-56, 2002
7. Pichette V, Leblond FA: Drug metabolism in chronic renal failure. Curr Drug Metab 4: 91-103, 2003
8. Nolin TD, Frye RF, Matzke GR: Hepatic drug metabolism and transport in patients with kidney disease. Am J Kidney Dis 42: 906-925, 2003
9. Dreisbach AW, Lertora JJ: The effect of chronic renal failure on hepatic drug metabolism and drug disposition. Semin Dial 16: 45-50, 2003
10. Gibson TP: Renal disease and drug metabolism: An overview. Am J Kidney Dis 8: 7-17, 1986
11. Leber HW, Gleumes L, Schutterle G: Enzyme induction in the uremic liver. Kidney Int Suppl S43-S48, 1978
12. Leber HW, Schutterle G: Oxidative drug metabolism in liver microsomes from uremic rats. Kidney Int 2: 152-158, 1972
13. Uchida N, Kurata N, Shimada K, Nishimura Y, Yasuda K, Hashimoto M, Uchida E, Yasuhara H: Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn J Pharmacol 68: 431-439, 1995
14. Patterson SE, Cohn VH: Hepatic drug metabolism in rats with experimental chronic renal failure. Biochem Pharmacol 33: 711-716, 1984
15. Leblond F, Guevin C, Demers C, Pellerin I, Gascon-Barre M, Pichette V: Downregulation of hepatic cytochrome P450 in chronic renal failure. J Am Soc Nephrol 12: 326-332, 2001
16. Leblond FA, Giroux L, Villeneuve JP, Pichette V: Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab Dispos 28: 1317-1320, 2000
17. Michaud J, Naud J, Chouinard J, Desy F, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V: Role of parathyroid hormone in the down-regulation of liver cytochrome P450 in chronic renal failure. J Am Soc Nephrol 17: 3041-3048, 2006
18. Boukouvala S, Fakis G: Arylamine N-acetyltransferases: What we learn from genes and genomes. Drug Metab Rev 37: 511-564, 2005
19. Klaassen CD: Cassarett and Doull's Toxicology: The Basic Science of Poisons, 6th Ed., New York, McGraw-Hill Professional Publishing, 2001
20. Singlas E, Pioger JC, Taburet AM, Colin JN, Fillastre JP: Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis. Clin Pharmacol Ther 46: 190-197, 1989
21. Osborne R, Joel S, Grebenik K, Trew D, Slevin M: The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 54: 158-167, 1993
22. Kim YG, Shin JG, Shin SG, Jang IJ, Kim S, Lee JS, Han JS, Cha YN: Decreased acetylation of isoniazid in chronic renal failure. Clin Pharmacol Ther 54: 612-620, 1993
23. Karlsson E: Clinical pharmacokinetics of procainamide. Clin Pharmacokinet 3: 97-107, 1978
24. du Souich P, Erill S: Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. Eur J Clin Pharmacol 14: 21-27, 1978
25. Yu C, Ritter JK, Krieg RJ, Rege B, Karnes TH, Sarkar MA: Effect of chronic renal insufficiency on hepatic and renal udp-glucuronyltransferases in rats. Drug Metab Dispos 34: 621-627, 2006
26. Sim E, Westwood I, Fullam E: Arylamine N-acetyltransferases. Expert Opin Drug Metab Toxicol 3: 169-184, 2007
27. Walraven JM, Doll MA, Hein DW: Identification and characterization of functional rat arylamine N-acetyltransferase 3: Comparisons with rat arylamine N-acetyltransferases 1 and 2. J Pharmacol Exp Ther 319: 369-375, 2006
28. Van Peer AP, Belpaire FM: Hepatic oxidative drug metabolism in rats with experimental renal failure. Arch Int Pharmacodyn Ther 228: 180-183, 1977
29. Guevin C, Michaud J, Naud J, Leblond FA, Pichette V: Down-regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators. Br J Pharmacol 137: 1039-1046, 2002
30. Michaud J, Dubé P, Naud J, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V: Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. Br J Pharmacol 144: 1067-1077, 2005
31. Lehmann CR, Heironimus JD, Collins CB, O'Neil TJ, Pierson WP, Crowe JT, Melikian AP, Wright GJ: Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Clin Pharmacol Ther 37: 284-289, 1985
32. Bateman DN, Gokal R, Dodd TR, Blain PG: The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol 19: 437-441, 1981
33. Taburet AM, Vincent I, Perello L, Corel B, Baune B, Furlan V: Impairment of drug biotransformation in renal disease an in vitro model. Am Soc Clin Pharmacol Ther 59: 136, 1996
34. Sun H, Huang Y, Frassetto L, Benet LZ: Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. Drug Metab Dispos 32: 1239-1246, 2004
35. Sun H, Frassetto L, Benet LZ: Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109: 1-11, 2006
36. Naud J, Michaud J, Boisvert C, Desbiens K, Leblond FA, Mitchell A, Jones C, Bonnardeaux A, Pichette V: Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 320: 978-985, 2007
37. Klin M, Smogorzewski M, Ni Z, Zhang G, Massry SG: Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest 97: 2167-2173, 1996
38. Qing DP, Ding H, Vadgama J, Wu YY, Kopple JD: Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol 10: 84-92, 1999
39. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD: Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure: Evidence for a postreceptor defect. J Clin Invest 97: 1064-1075, 1996
40. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC: Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282: 1-17, 2002
41. Picotto G, Massheimer V, Boland R: Parathyroid hormone stimulates calcium influx and the cAMP messenger system in rat enterocytes. Am J Physiol 273: C1349-C1353, 1997
42. Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo JM, de Landazuri MO: Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: Modulation of NF-kappa B and AP-1 transcription factors activity. Blood 88: 3482-3490, 1996
43. Schneck DW, Sprouse JS, Hayes AH Jr, Shiroff RA: The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase. J Pharmacol Exp Ther 204: 212-218, 1978
44. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
45. Towbin H, Staehlin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellose sheets. Proc Natl Acad Sci U S A 76: 4350-4354, 1979
46. Stanley LA, Coroneos E, Cuff R, Hickman D, Ward A, Sim E: Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem 44: 1059-1067, 1996
47. Takeshita F, Ogawa K, Asamoto M, Shirai T: Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Lett 194: 25-35, 2003
48. Kobayashi K, Utsumi H, Okada M, Sakairi T, Ikeda I, Kusakabe M, Takagi S: One-step RT-PCR without initial RNA isolation step for laser-microdissected tissue sample. J Vet Med Sci 65: 917-919, 2003
49. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001
50. Andres HH, Klem AJ, Szabo SM, Weber WW: New spectrophotometric and radiochemical assays for acetyl-CoA: Arylamine N-acetyltransferase applicable to a variety of arylamines. Anal Biochem 145: 367-375, 1985
51. Mattano SS, Weber WW: Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis 8: 133-137, 1987